5 Key Takeaways
-
1
Cascader, a UK medtech spinout, has completed a seed funding round led by Topcon Healthcare to develop AI tools for eye care.
-
2
The company aims to translate AI from academic research into tools for routine clinical care, focusing initially on macular diseases.
-
3
Cascader plans to utilize ocular imaging to generate insights into systemic conditions, including cardiovascular and neurodegenerative diseases.
-
4
The company builds on over a decade of AI research at the UCL Institute of Ophthalmology and Moorfields Eye Hospital.
-
5
Cascader will receive support from the INSIGHT Eye and Oculomics Health Data Research Hub for AI development.
This content is an AI-generated, fully rewritten summary based on a published scholarly article. It does not reproduce the original text and is not a substitute for the original publication. Readers are encouraged to consult the source for full context, data, and methodology.
